MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
The University of Oxford is the First In Europe to Aquire Latest MEG Technology from MEGIN

The University of Oxford is the First In Europe to Aquire Latest MEG Technology from MEGIN

by MEGIN | Feb 18, 2018 | MEGIN News

OXFORD, UNITED KINGDOM (February 08, 2019) – MEGIN is pleased to announce that the University of Oxford is the first in Europe to acquire the latest technology in functional brain imaging. TRIUX™ neo, a magnetoencephalograph (MEG), is a highly sensitive non-invasive...
Next Entries »

Home
About us
MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.